Heat Release Extra Capsules
Natural health product licensed in Canada
- Other names
- Lianhua Qingwen Capsules
- Licence holder
- Dr. Ma's Laboratories Inc.
- NPN or DIN-HM
- 80106270
- Status
- Active licence
- Licence date
- 17 November 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Rheum palmatum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Prunus armeniaca Source : Graine Extract : Matériel brut sec Extraction ratio : 7.699:1 Dry plant equivalent : 85 mg | 11.04 mg | Not calculated |
| Glycyrrhiza uralensis Source : Rhizome Extract : Matériel brut sec Extraction ratio : 7.699:1 Dry plant equivalent : 85 mg | 11.04 mg | Not calculated |
| Gypsum Fibrosum Source : Gypsum fibrosum | 22.1 mg | Not calculated |
| Forsythia suspensa Source : Fruit Extract : Matériel brut sec Extraction ratio : 6.8:1 Dry plant equivalent : 255 mg | 37.5 mg | Not calculated |
| Lonicera japonica Source : Fleur Extract : Matériel brut sec Extraction ratio : 7.699:1 Dry plant equivalent : 255 mg | 33.12 mg | Not calculated |
| Ephedra sinica Source : Tige Extract : Matériel brut sec Extraction ratio : 6.8:1 Dry plant equivalent : 85 mg | 12.5 mg | Not calculated |
| Dryopteris crassirhizoma Source : Rhizome Extract : Matériel brut sec Extraction ratio : 7.699:1 Dry plant equivalent : 255 mg | 33.12 mg | Not calculated |
| Isatis tinctoria Source : Racine Extract : Matériel brut sec Extraction ratio : 7.699:1 Dry plant equivalent : 255 mg | 33.12 mg | Not calculated |
| l-Menthol Source : Mentholum | 7.5 mg | Not calculated |
| Pogostemon cablin Source : Sommité Extract : Matériel brut sec Extraction ratio : 100:2 Dry plant equivalent : 85 mg | 170 mg | Not calculated |
| Rhodiola rosea Source : Racine et rhizome Extraction ratio : 7.669:1 Dry plant equivalent : 85 mg Potency : 3 % Rosavins | 11.04 mg | Not calculated |
| Houttuynia cordata Source : Sommité Extract : Matériel brut sec Extraction ratio : 6.8:1 Dry plant equivalent : 255 mg | 37.5 mg | Not calculated |
| Rheum palmatum Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 6.8:1 Dry plant equivalent : 51 mg | 7.5 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Maltodextrine, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 4 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
This traditional Chinese Medicine helps remove heat-toxin invasion of the lung, including symptoms such as fever, aversion to cold, muscular soreness, stuffy and runny nose, dry and sore throat, red tongue with yellow and greasy coating.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80106270
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.